{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:11:46Z","timestamp":1786986706031,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,17]],"date-time":"2014-04-17T00:00:00Z","timestamp":1397692800000},"content-version":"vor","delay-in-days":381,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Host & Microbe"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.chom.2013.03.001","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T06:00:53Z","timestamp":1366264853000},"page":"417-428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Disease-Enhancing Antibodies Improve the Efficacy of Bacterial Toxin-Neutralizing Antibodies"],"prefix":"10.1016","volume":"13","author":[{"given":"Siu-Kei","family":"Chow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"MacCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary\u00a0Ann","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviv","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chom.2013.03.001_bib1","doi-asserted-by":"crossref","first-page":"25077","DOI":"10.1074\/jbc.M109.022061","article-title":"Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies","volume":"284","author":"Abboud","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chom.2013.03.001_bib2","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1084\/jem.20100995","article-title":"A requirement for Fc\u03b3R in antibody-mediated bacterial toxin neutralization","volume":"207","author":"Abboud","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.chom.2013.03.001_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/286529","article-title":"The theory of emergence","volume":"6","author":"Ablowitz","year":"1939","journal-title":"Phil. Sci."},{"key":"10.1016\/j.chom.2013.03.001_bib4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.immunol.17.1.593","article-title":"Mechanisms of phagocytosis in macrophages","volume":"17","author":"Aderem","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.chom.2013.03.001_bib5","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1073\/pnas.87.6.2274","article-title":"Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells","volume":"87","author":"Anderson","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2013.03.001_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.283.5400.381","article-title":"Emergent properties of networks of biological signaling pathways","volume":"283","author":"Bhalla","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.chom.2013.03.001_bib7","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1128\/IAI.72.11.6313-6317.2004","article-title":"Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies","volume":"72","author":"Brossier","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2013.03.001_bib8","doi-asserted-by":"crossref","first-page":"e1002136","DOI":"10.1371\/journal.ppat.1002136","article-title":"Microbial virulence as an emergent property: consequences and opportunities","volume":"7","author":"Casadevall","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chom.2013.03.001_bib9","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1128\/IAI.00200-09","article-title":"Novel chimpanzee\/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody","volume":"77","author":"Chen","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2013.03.001_bib10","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1128\/IAI.00405-09","article-title":"Antibody protection against botulinum neurotoxin intoxication in mice","volume":"77","author":"Cheng","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2013.03.001_bib11","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.vaccine.2010.12.134","article-title":"Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis","volume":"29","author":"Chow","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2013.03.001_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/toxins4060430","article-title":"Monoclonal antibodies and toxins\u2014a perspective on function and isotype","volume":"4","author":"Chow","year":"2012","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.chom.2013.03.001_bib13","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1039\/c1mb05077j","article-title":"Guidelines for visualizing and annotating rule-based models","volume":"7","author":"Chylek","year":"2011","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.chom.2013.03.001_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1128\/JVI.63.1.36-42.1989","article-title":"Inhibition of rhinovirus attachment by neutralizing monoclonal antibodies and their Fab fragments","volume":"63","author":"Colonno","year":"1989","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2013.03.001_bib15","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1365-2958.2010.07511.x","article-title":"Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity","volume":"79","author":"Cordero","year":"2011","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.chom.2013.03.001_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/cplx.10043","article-title":"The re-emergence of \u201cemergence\u201d: a venerable concept in search for a theory","volume":"7","author":"Corning","year":"2002","journal-title":"Complexity"},{"key":"10.1016\/j.chom.2013.03.001_bib17","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1128\/EC.00268-09","article-title":"Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable","volume":"9","author":"De Jesus","year":"2010","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.chom.2013.03.001_bib18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.chom.2013.03.001_bib19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4161\/mabs.2.2.11220","article-title":"Neutralization of Clostridium difficile toxin A using antibody combinations","volume":"2","author":"Demarest","year":"2010","journal-title":"MAbs"},{"key":"10.1016\/j.chom.2013.03.001_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(80)90146-5","article-title":"Production of monoclonal antibodies: strategy and tactics","volume":"35","author":"de StGroth","year":"1980","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.chom.2013.03.001_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-59745-525-1_5","article-title":"Rule-based modeling of biochemical systems with BioNetGen","volume":"500","author":"Faeder","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.chom.2013.03.001_bib22","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3390\/toxins3111433","article-title":"Antibodies against anthrax: mechanisms of action and clinical applications","volume":"3","author":"Froude","year":"2011","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.chom.2013.03.001_bib23","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1021\/j100540a008","article-title":"Exact stochastic simulation of coupled chemical reactions","volume":"81","author":"Gillespie","year":"1977","journal-title":"J.\u00a0Phys. Chem."},{"key":"10.1016\/j.chom.2013.03.001_bib24","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1080\/01621459.1985.10478210","article-title":"Exact power of goodness-of-fit tests of Kolmogorov type for discontinuous distributions","volume":"80","author":"Gleser","year":"1985","journal-title":"J.\u00a0Am. Stat. Assoc."},{"key":"10.1016\/j.chom.2013.03.001_bib25","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1099\/0022-1317-69-8-2101","article-title":"Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus","volume":"69","author":"Henchal","year":"1988","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.chom.2013.03.001_bib26","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1128\/JB.00182-10","article-title":"A systems biology approach to modeling vibrio cholerae gene expression under virulence-inducing conditions","volume":"192","author":"Kanjilal","year":"2010","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.chom.2013.03.001_bib27","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jmb.2009.07.037","article-title":"The protective antigen component of anthrax toxin forms functional octameric complexes","volume":"392","author":"Kintzer","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chom.2013.03.001_bib28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.chom.2013.03.001_bib29","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/IAI.56.7.1807-1813.1988","article-title":"Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin","volume":"56","author":"Little","year":"1988","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2013.03.001_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1574-695X.2011.00782.x","article-title":"Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in\u00a0vivo","volume":"62","author":"Little","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.chom.2013.03.001_bib31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tibtech.2007.07.005","article-title":"Antibody cocktails: next-generation biopharmaceuticals with improved potency","volume":"25","author":"Logtenberg","year":"2007","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.chom.2013.03.001_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJMoa0907635","article-title":"Treatment with monoclonal antibodies against Clostridium difficile toxins","volume":"362","author":"Lowy","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2013.03.001_bib33","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.4049\/jimmunol.172.10.6221","article-title":"Immunological characteristics associated with the protective efficacy of antibodies to ricin","volume":"172","author":"Maddaloni","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.chom.2013.03.001_bib34","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1083\/jcb.98.4.1170","article-title":"Internalization and degradation of macrophage Fc receptors bound to polyvalent immune complexes","volume":"98","author":"Mellman","year":"1984","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.chom.2013.03.001_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa0810603","article-title":"Raxibacumab for the treatment of inhalational anthrax","volume":"361","author":"Migone","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chom.2013.03.001_bib36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.mam.2009.07.003","article-title":"Cellular and systemic effects of anthrax lethal toxin and edema toxin","volume":"30","author":"Moayeri","year":"2009","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.chom.2013.03.001_bib37","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1073\/pnas.052160199","article-title":"The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen","volume":"99","author":"Mogridge","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2013.03.001_bib38","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1128\/IAI.72.6.3276-3283.2004","article-title":"Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages","volume":"72","author":"Mohamed","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2013.03.001_bib39","doi-asserted-by":"crossref","first-page":"16396","DOI":"10.1016\/S0021-9258(18)42016-9","article-title":"Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen","volume":"267","author":"Molloy","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chom.2013.03.001_bib40","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature09385","article-title":"Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation","volume":"467","author":"Mouquet","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.chom.2013.03.001_bib41","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1128\/IAI.60.11.4534-4541.1992","article-title":"Protective murine monoclonal antibodies to Cryptococcus neoformans","volume":"60","author":"Mukherjee","year":"1992","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2013.03.001_bib42","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1128\/CVI.05714-11","article-title":"Analysis of defined combinations of monoclonal antibodies in anthrax toxin neutralization assays and their synergistic action","volume":"19","author":"Ngundi","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.chom.2013.03.001_bib43","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1084\/jem.183.4.1905","article-title":"Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans","volume":"183","author":"Nussbaum","year":"1996","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.chom.2013.03.001_bib44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/282509a0","article-title":"Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines","volume":"282","author":"Peiris","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.chom.2013.03.001_bib45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/35084083","article-title":"The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination","volume":"412","author":"Pethe","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.chom.2013.03.001_bib46","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.chom.2013.03.001_bib47","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1084\/jem.132.4.737","article-title":"Common individual antigenic determinants in five of eight BALB-c IgA myeloma proteins that bind phosphoryl choline","volume":"132","author":"Potter","year":"1970","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.chom.2013.03.001_bib48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.chom.2013.03.001_bib49","doi-asserted-by":"crossref","first-page":"14070","DOI":"10.1073\/pnas.1006473107","article-title":"Anthrax toxin-neutralizing antibody reconfigures the protective antigen heptamer into a supercomplex","volume":"107","author":"Radjainia","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2013.03.001_bib50","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1128\/IAI.00150-06","article-title":"A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1","volume":"74","author":"Rivera","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2013.03.001_bib51","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nbt1207-1369","article-title":"Isotype selection in antibody engineering","volume":"25","author":"Salfeld","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"Suppl 6","key":"10.1016\/j.chom.2013.03.001_bib52","doi-asserted-by":"crossref","first-page":"G38","DOI":"10.1016\/j.vaccine.2009.09.105","article-title":"Monoclonal antibody-based therapies for microbial diseases","volume":"27","author":"Saylor","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.chom.2013.03.001_bib53","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.chom.2013.03.001_bib54","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.4049\/jimmunol.170.7.3621","article-title":"More is not necessarily better: prozone-like effects in passive immunization with IgG","volume":"170","author":"Taborda","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.chom.2013.03.001_bib55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/rmv.405","article-title":"Antibody-dependent enhancement of viral infection: molecular mechanisms and in\u00a0vivo implications","volume":"13","author":"Takada","year":"2003","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.chom.2013.03.001_bib56","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0092-8674(94)90115-5","article-title":"FcR gamma chain deletion results in pleiotrophic effector cell defects","volume":"76","author":"Takai","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.chom.2013.03.001_bib57","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.2972065","article-title":"Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry","volume":"242","author":"Takeda","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.chom.2013.03.001_bib58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1128\/JVI.54.1.7-13.1985","article-title":"A monoclonal antibody that neutralizes poliovirus by cross-linking virions","volume":"54","author":"Thomas","year":"1985","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chom.2013.03.001_bib59","doi-asserted-by":"crossref","first-page":"9737","DOI":"10.1074\/jbc.M110.212407","article-title":"Generation, characterization, and epitope mapping of neutralizing and protective monoclonal antibodies against staphylococcal enterotoxin B-induced lethal shock","volume":"286","author":"Varshney","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chom.2013.03.001_bib60","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/IAI.51.3.795-800.1986","article-title":"Differences in susceptibility of inbred mice to Bacillus anthracis","volume":"51","author":"Welkos","year":"1986","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2013.03.001_bib61","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1128\/IAI.01101-09","article-title":"Neutralizing monoclonal antibody to edema toxin and its effect on murine anthrax","volume":"78","author":"Winterroth","year":"2010","journal-title":"Infect. Immun."}],"container-title":["Cell Host & Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193131281300111X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193131281300111X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:34:07Z","timestamp":1644798847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193131281300111X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S193131281300111X"],"URL":"https:\/\/doi.org\/10.1016\/j.chom.2013.03.001","relation":{},"ISSN":["1931-3128"],"issn-type":[{"value":"1931-3128","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease-Enhancing Antibodies Improve the Efficacy of Bacterial Toxin-Neutralizing Antibodies","name":"articletitle","label":"Article Title"},{"value":"Cell Host & Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chom.2013.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}